P076 TRANSFERABLE IMMUNE REACTIVE MICROBIOTA DETERMINE CLINICAL AND IMMUNOLOGIC OUTCOME OF FECAL MICROBIOTA TRANSPLANTATION FOR ULCERATIVE COLITIS
Abstract Background Biologic therapy has significantly improved treatment for UC, but nearly two-thirds of patients attenuate response. Additional therapeutic modalities are therefore needed to address the underlying pathophysiology of UC. Fecal microbiota transplant (FMT) is an emerging therapy for...
Gespeichert in:
Veröffentlicht in: | Inflammatory bowel diseases 2020-01, Vol.26 (Supplement_1), p.S39-S39 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!